Hokusai-VTE study suggests certain sub-groups of venous thromboembolism patients may need review
Monday, September 2, 2013 - 13:00
in Health & Medicine
In the treatment of venous thromboembolism (VTE), the oral anticoagulant edoxaban resulted in equal efficacy and better safety compared to standard warfarin when either drug was used with initial low molecular weight heparin, according to the results of the Hokusai-VTE trial.